We are proud to announce that Professor Giuseppe Lanza, Editors-in-Chief of of Advances in Clinical and Translational Medicine (ACTM), together with 3 distinguished Editorial Board members, have been named on the World's Top 2% Scientists 2026 list. This prestigious accolade acknowledges their outstanding research contributions and far-reaching global impact across clinical medicine, translational...